RE:Bad news?We have already numerous pre-clinical dats for PBI-4050, so it's not the kind of news that I was expecting to make the SP climb.
If I was a rat, I would be happy to see that all my vital organs can be treated, but until with get conclusive clinical trial in human.......
The lack of news regarding deals suggest that the income won't be what is expected. A year ago, I would have been more concern.
But since the serious turn into the orphan drugs and the two last financing providing $ 32M of cash, all I can say is the company is in better shape.
And I'm a buyer as soon as we touch 80 cents, if it's still going down.